Trade Summary

3 days ago, Henderson Michael Thomas, serving as CEO at Apogee Therapeutics, Inc. (APGE), sold 20,000 shares at $82.09 per share, for a total transaction value of $1,641,711.00. Following this transaction, Henderson Michael Thomas now holds 1,115,987 shares of APGE.

This sale represents a 2.00% decrease in Henderson Michael Thomas's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 8:00 PM ET, 2 days after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.